Hepatitis C screening of the "birth cohort" (born 1945-1965) and younger inmates of New York City jails

American Journal of Public Health

Volumn 106, Issue 7, 2016, Pages 1276-1277

  Akiyama, Matthew J ^a   Kaba, Fatos ^a   Rosner, Zachary ^b   Alper, Howard ^b   Holzman, Robert S ^a   MacDonald, Ross ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

AGE DISTRIBUTION; AGED; ELECTRONIC HEALTH RECORD; FEMALE; HEPATITIS C; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; NEW YORK; PREVALENCE; PRISON; PRISONER; SEROEPIDEMIOLOGY; STATISTICS AND NUMERICAL DATA;

AGE DISTRIBUTION; AGED; ELECTRONIC HEALTH RECORDS; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEW YORK CITY; PREVALENCE; PRISONERS; PRISONS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84974652619     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2016.303163     Document Type: Article

References (10)

1. Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49(4):1335-1374.
2. Varan AK, Mercer DW, Stein MS, Spaulding AC. Hepatitis C seroprevalence among prison inmates since 2001: still high but declining. Public Health Rep. 2014; 129(2):187-195.
3. Lattin D, Bennett DM. Jail Capacity Planning: A Systems Approach. Washington, DC: US Department of Justice National Institute of Corrections; 2009.
4. Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61:1-32.
5. Spaulding AS, Kim AY, Harzke AJ, et al. Impact of new therapeutics for hepatitis C virus in incarcerated populations. Top Antivir Med. 2013;21(1):27-35.
6. Larney S, Mahowald MK, Scharff N, Flanigan TP, Beckwith CG, Zaller ND. Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings. Am J Public Health. 2014;104(6):e69-e74.
7. New York City Department of Health and Mental Hygiene, Correctional Health Services. Medical Policy on Hepatitis C Screening, Education and Discharge Planning. Queens, NY: New York City Department of Health and Mental Hygiene, Correctional Health Services; June 2013.
8. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39.
9. AmonJJ, Garfein RS,Ahdieh-Grant L, et al. Prevalence of hepatitisCvirus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis. 2008; 46(12):1852-1858.
10. Liu S, Cipriano LE, Holodniy M, Goldhaber-Fiebert JD. Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States. PLoS One. 2013;8(3):e58975.